G-CSF Prophylaxis in High-Risk Female Patients with solid Tumors in clinical Practice: IMPACT SOLID Study

被引:0
|
作者
Vavra, C. [1 ,2 ]
Singer, C. [3 ]
Staudigl, C. [3 ]
Hubalek, M. [4 ]
Unterrieder, K.
Jaeger, C. [5 ]
Sevelda, P. [1 ,2 ]
机构
[1] Krankenhaus Hietzing Neurol Zentrum Rosenhugel, Gynakol Geburtshilfliche Abt, Vienna, Austria
[2] Karl Landsteiner Inst Gynakolog Onkol & Senol, Vienna, Austria
[3] Med Univ Wien, Univ Klin Frauenheilkunde, Vienna, Austria
[4] Med Univ Innsbruck, Univ Klin Frauenheilkunde, Klin Abt Gynakol & Geburtshilfe, Innsbruck, Austria
[5] Amgen GmbH, Vienna, Austria
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] DEFENDOR: Real-world evidence of primary prolonged G-CSF prophylaxis by empegfilgrastim for relative dose intensity compliance in patients with solid tumors-The final analysis
    Snegovoy, Anton
    Kononenko, Inessa
    Radyukova, Irina
    Orlova, Svetlana
    Starostina, Tatiyana
    Sultanbaev, Alexander Valerievich
    Dubovichenko, Daria
    Dergunov, Alexander
    Saydullaeva, Alexandra
    Repina, Nadezhda
    Gronskaya, Yulia
    Rossokha, Elena
    Sorokina, Irina
    Prosianikova, Oksana
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Emerging epigenetic targets in high-risk pediatric solid tumors
    Stegmaier, Kimberly
    CANCER RESEARCH, 2016, 76
  • [33] Escalated dose docetaxel (TXT) with G-CSF support in patients (PTS) with solid tumours
    Mitchell, P
    Basser, R
    Ng, S
    Gibbs, P
    Chipman, M
    Grigg, A
    Gargano, J
    Riva, A
    Appia, F
    Green, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S288 - S288
  • [34] Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022
    Eiki Ichihara
    Nobuaki Ochi
    Go Makimoto
    Kenichiro Kudo
    Daijiro Harada
    Yukinori Ozaki
    Hiroshi Nishio
    Kenji Tsuchihashi
    Yuji Miura
    Makoto Endo
    Shingo Yano
    Dai Maruyama
    Tetsuhiro Yoshinami
    Nobuyuki Susumu
    Munetaka Takekuma
    Takashi Motohashi
    Mamoru Ito
    Eishi Baba
    Keita Uchino
    Takahiro Kimura
    Yutaro Kamiyama
    Shinji Nakao
    Shinobu Tamura
    Hitomi Nishimoto
    Yasuhisa Kato
    Atsushi Sato
    Toshimi Takano
    Toshio Kubo
    International Journal of Clinical Oncology, 2024, 29 : 355 - 362
  • [35] A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors
    Huber, MH
    Lee, JS
    Newman, RA
    Fossella, FV
    Wester, M
    Hong, WK
    Lippman, SM
    ANNALS OF ONCOLOGY, 1996, 7 (01) : 59 - 63
  • [36] Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022
    Ichihara, Eiki
    Ochi, Nobuaki
    Makimoto, Go
    Kudo, Kenichiro
    Harada, Daijiro
    Ozaki, Yukinori
    Nishio, Hiroshi
    Tsuchihashi, Kenji
    Miura, Yuji
    Endo, Makoto
    Yano, Shingo
    Maruyama, Dai
    Yoshinami, Tetsuhiro
    Susumu, Nobuyuki
    Takekuma, Munetaka
    Motohashi, Takashi
    Ito, Mamoru
    Baba, Eishi
    Uchino, Keita
    Kimura, Takahiro
    Kamiyama, Yutaro
    Nakao, Shinji
    Tamura, Shinobu
    Nishimoto, Hitomi
    Kato, Yasuhisa
    Sato, Atsushi
    Takano, Toshimi
    Kubo, Toshio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (04) : 355 - 362
  • [37] Tumour cell detection in G-CSF mobilised stem cell harvests of patients with high-risk breast cancer
    Krüger, WH
    Tögel, F
    Kröger, N
    Renges, H
    Rauhöft, C
    Lindner, C
    Jänicke, F
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1999, 23 : S147 - S147
  • [38] ADMINISTRATION OF GRANULOCYTE-COLONY STIMULATING FACTORS (G-CSF) IN SOLID TUMORS. AN ITALIAN OBSERVATIONAL STUDY BY THE OBSERVE STUDY GROUP
    Barni, S.
    Lorusso, V.
    Giordano, M.
    Santoro, A.
    Todeschini, R.
    Piazza, E.
    Zilembo, N.
    Naglieri, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 382 - 382
  • [39] Defendor: Real-world evidence of primary prolonged G-CSF prophylaxis by empegfilgrastim for relative dose intensity compliance in patients with solid tumors-The primary analysis.
    Snegovoy, Anton
    Dergunov, Alexander
    Tatyanenko, Anna
    Yakuba, Darya
    Elkova, Viktoriya
    Shalina, Anna
    Komoza, Yulia
    Dmitrochenko, Marina
    Soroka, Svetlana
    Shegurova, Margarita
    Chapko, Yana
    Dmitriev, Vadim
    Timin, Vladimir
    Rossokha, Elena
    Gronskaya, Yulia
    Kononenko, Inessa
    Sorokina, Irina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18788 - E18788
  • [40] G-CSF primed peripheral blood progenitor cells (PBPC) autotransplantation in Stage IV Neuroblastoma and poor risk solid tumors.
    Dallorso, S
    Dini, G
    Miano, M
    Rivabella, L
    Scarso, L
    Martinengo, M
    Kotitsa, Z
    Franchini, E
    Garaventa, A
    Lanino, E
    Rondelli, R
    BONE MARROW TRANSPLANTATION, 1996, 18 : 182 - 184